Cite

HARVARD Citation

    Luo, Y. et al. (2021). Remarkable response to anti-PD1 immunotherapy in refractory metastatic high-grade myxofibrosarcoma patient. Medicine. 100 (12), p. . [Online]. 
  
Back to record